Redhill Biopharma Stock Widgets and Gadgets
| RDHL Stock | USD 0.40 0.03 6.98% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RDHL Redhill Biopharma
- Latest AscellaHealth Expands Executive Team Industry Veterans Lead Development and Implementation of End-to-End Payer Solutions and Pharmacy Operations to Control Specialty Spend
- RDHL 0.4 -0.03
- Low 0.4
- High 0.44
- Volume 355.8 K
- Alpha -1.36
- Beta -0.52
- Return On Equity -8.84
- Return On Asset -0.16
- Profit Margin 3.66 %
- Operating Margin (10.61) %
- Current Valuation 9.16 M
- Shares Outstanding 31.87 M
- Shares Owned By Institutions 6.24 %
- Number Of Shares Shorted 906.88 K
- Price To Earning (3.67) X
- Price To Book 6.55 X
- Price To Sales 2.08 X
- Revenue 6.51 M
- Gross Profit 45.25 M
- EBITDA (29.37 M)
- Net Income 23.85 M
- Cash And Equivalents 28.86 M
- Cash Per Share 0.55 X
- Total Debt 1.17 M
- Debt To Equity 9.89 %
- Current Ratio 0.98 X
- Book Value Per Share 0.24 X
- Cash Flow From Operations (35.73 M)
- Short Ratio 1.12 X
- Earnings Per Share 4.00 X
- Target Price 760.0
- Beta 3.46
- Market Capitalization 13.56 M
- Total Asset 23.05 M
- Retained Earnings (407.74 M)
- Working Capital (3.1 M)
- Current Asset 60.51 M
- Current Liabilities 5.51 M
- Net Asset 23.05 M
- Accumulation Distribution 32346.45
- Daily Balance Of Power (0.75)
- Rate Of Daily Change 0.93
- Day Median Price 0.42
- Day Typical Price 0.41
- Price Action Indicator (0.04)
- Period Momentum Indicator (0.03)
- Relative Strength Index 38.83
Market Snapshot Widget Example
DAX Index Germany | 18,027 0.54 | |
Taiwan Weighted Taiwan | 20,450 1.38 | |
PSI 20 Stock Portugal | 6,269 1.08 | |
CROBEX Croatia | 2,832 0.06 | |
Budapest SE Hungary | 67,408 0.18 | |
IDX 30 Jakarta Indonesia | 488.17 0.23 | |
ISEQ 20 Price Ireland | 1,643 0.84 | |
NYSE Comp USA | 17,507 0.75 | |
Tel Aviv 35 Israel | 1,914 0.96 | |
Coreshares Index Tracker South Afric | 1,040 0.57 | |
IPC MEXICO Mexico | 55,984 1.03 | |
KL Technology Malaysia | 64.96 0.40 | |
IBEX 35 Index Spain | 10,687 0.01 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,539 0.44 | |
SPASX Dividend Opportunities Australia | 1,685 0.22 | |
HNX 30 Vietnam | 494.92 7.92 | |
Bucharest BET-NG Romania | 1,210 0.09 | |
AMS Small Cap Netherlands | 1,230 1.55 | |
Oslo Exchange Mutual Norway | 1,309 0.87 | |
BEL Small Belgium | 9,118 1.91 | |
RTSI Index Russia | 1,168 0.15 | |
Basic Materials Brazil | 5,926 0.53 | |
Swiss Leader Price Switzerland | 1,870 0.26 | |
Fondo Mutuo ETF Chile | 1,438 1.12 | |
Athens General Comp Greece | 1,391 0.71 | |
Stock Exchange Of Thailand | 1,396 0.84 | |
PX Prague Stock Czech Repub | 1,559 0.78 | |
THE PHILIPPINE STOCK Philippines | 6,562 1.46 | |
WIG 30 Poland | 3,042 0.39 | |
BIST Electricity Turkey | 580.96 1.12 |
Investing Ideas
In addition to having Redhill Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Redhill Biopharma
Compare Redhill Biopharma To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.Note that the Redhill Biopharma information on this page should be used as a complementary analysis to other Redhill Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Redhill Stock analysis
When running Redhill Biopharma's price analysis, check to measure Redhill Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redhill Biopharma is operating at the current time. Most of Redhill Biopharma's value examination focuses on studying past and present price action to predict the probability of Redhill Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redhill Biopharma's price. Additionally, you may evaluate how the addition of Redhill Biopharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Redhill Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 4 | Revenue Per Share 1.092 | Quarterly Revenue Growth (0.96) | Return On Assets (0.16) | Return On Equity (8.84) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.